Skip to content

Prospective Intervention Study to Improve HRQoL and Exercise Tolerance After Heart Transplantation

Prospective Intervention Study to Improve HRQoL and Exercise Tolerance After Heart Transplantation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00752336
Acronym
Ergo-HTx
Enrollment
87
Registered
2008-09-15
Start date
2002-01-31
Completion date
2009-09-30
Last updated
2008-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise Capacity, Heart Transplantation

Keywords

HRQoL, exercise capacity

Brief summary

A prospective, interventional rehabilitation program was initiated to improve exercise tolerance and psychosocial functioning in patients after heart transplantation (HTx) and to evaluate long-term effects on health-related quality of life (HRQoL).Study subjects were randomized to either intervention or to control group and were followed with regular cardiopulmonary exercise testings and HRQoL measurements (SF-36) for 36±3 months after HTx. Patient characteristics did not differ concerning age, gender, and diagnosis at study entry. IG patients received regular psychosocial support and performed a home-based supervised ergometer training program. CG patients were recommended to perform regular exercising.

Interventions

supervised home-based endurance training; recommendation to exercise every other day

Sponsors

Roche Pharma AG
CollaboratorINDUSTRY
Hannover Medical School
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 67 Years
Healthy volunteers
Yes

Inclusion criteria

Heart transplant (6-9 mts post Tx) stabile health condition at study entry (pt stays within home environment) * Age ≥ 18 yrs * Sufficient language skills to answer questionnaire * Follow-up at our center * Willingness to participate by written informed consent

Exclusion criteria

* TVP diagnosis before study inclusion * Episodes of recurrent acute rejections * Medical contra-indication for regular exercise ergometer training * Malignancy

Design outcomes

Primary

MeasureTime frame
HRQoL,exercise capacity36 mts

Secondary

MeasureTime frame
Weight gain; cardiovascular risk factors; social re-integration36 mts

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026